ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02984995
Brief Title: Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation

First Submitted : December 5, 2016
First Submitted that Met QC Criteria : December 5, 2016
First Posted : December 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 8, 2019
Last Update Posted : February 12, 2019